WO2000035507A1 - Implant for implantation in humans or animals comprising flexible, thread-shaped elements - Google Patents

Implant for implantation in humans or animals comprising flexible, thread-shaped elements Download PDF

Info

Publication number
WO2000035507A1
WO2000035507A1 PCT/SE1999/002185 SE9902185W WO0035507A1 WO 2000035507 A1 WO2000035507 A1 WO 2000035507A1 SE 9902185 W SE9902185 W SE 9902185W WO 0035507 A1 WO0035507 A1 WO 0035507A1
Authority
WO
WIPO (PCT)
Prior art keywords
thread
implant
threads
humans
animals
Prior art date
Application number
PCT/SE1999/002185
Other languages
French (fr)
Inventor
Bengt Edberg
Original Assignee
Artimplant Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to SK479-2001A priority Critical patent/SK4792001A3/en
Priority to NZ511709A priority patent/NZ511709A/en
Priority to HU0104461A priority patent/HUP0104461A3/en
Priority to DE69905198T priority patent/DE69905198T2/en
Priority to BR9916030-7A priority patent/BR9916030A/en
Priority to SI9920088A priority patent/SI20622A/en
Priority to EP99973391A priority patent/EP1140236B1/en
Application filed by Artimplant Ab filed Critical Artimplant Ab
Priority to PL99347670A priority patent/PL347670A1/en
Priority to AU14388/00A priority patent/AU751967B2/en
Priority to US09/868,055 priority patent/US6626942B1/en
Priority to IL14362799A priority patent/IL143627A0/en
Priority to CA002354448A priority patent/CA2354448A1/en
Priority to KR1020017007350A priority patent/KR20010089569A/en
Priority to AT99973391T priority patent/ATE231731T1/en
Priority to DK99973391T priority patent/DK1140236T3/en
Priority to JP2000587825A priority patent/JP2002532156A/en
Publication of WO2000035507A1 publication Critical patent/WO2000035507A1/en
Priority to NO20012613A priority patent/NO20012613L/en
Priority to HK02104519.2A priority patent/HK1042658A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/08—Muscles; Tendons; Ligaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable

Definitions

  • Implant for implantation in humans or animals comprising flexible, thread- shaped elements
  • the present invention relates to an implant for implantation in, in particular, humans, which implant comprises flexible, thread-shaped elements and is particularly suitable for replacing ruptured articular ligaments.
  • the implant is intended to be a temporary implant which disintegrates in time into fragments which are so small that they can be transported away by the blood and excreted through the kidneys.
  • a damaged ligament can be treated by surgical intervention or by conservative therapy.
  • conservative therapy remains the most frequently used alternative.
  • a major reason for this is that existing operative techniques using existing implants are considered to be inadequate.
  • a common feature of all types of reconstruction is that the surgeon has to use some form of replacement material to replace the damaged tissue.
  • the most frequently used type of replacement material is tissue of the patient himself (autograft) which the surgeon takes from other parts of the body. This tissue is often supplemented with a synthetic material as reinforcement (augmentation implant). Alternatively, use is made of only a synthetic material (prosthetic implant).
  • Implant materials which have been tried over the last 20 years in addition to autografts are inter alia tendons from animals (xenografts), deceased humans (allografts), synthetic materials in the form of non-degradable bands (Dacron, polyethylene, polypropylene, carbon fibres, polytetrafluoroethylene), and a degradable band made of polydioxanone.
  • Temporary implants for implantation in humans or animals comprising flexible, thread-shaped elements are previously known.
  • One such has been described in Swedish patent specification 457392.
  • the implant according to this patent specification consists of a bioresorbable material and is intended to replace completely or partly a tendon, a ligament or a cruciate ligament.
  • the implant has an elongate shape and is flexible. Its main characteristic is that the structure has longitudinal grooves or ducts intended to serve as initial growth guides for new fibrous tissue.
  • a large number of bioresorbable materials are also known and used for other types of implant.
  • the synthetic non-degradable implant materials have proved to have inadequate tissue-affinity and in the majority of cases inadequate elasticity with creep or fatigue failure as a consequence.
  • a porous, in humans or animals biodegradable, biocompatible implant for implantation in humans or animals comprising flexible, thread-shaped elements has consequently been produced, which is characterized in that the thread-shaped elements consist of a number of thread bundles containing up to several thousand threads which in turn contain 50 to 500 filaments with a combined density of 5 to 120 tex, the thread bundles having a twist of 0 to 150 revolutions/metre and being held together by weft threads with a distribution density of a few threads per cm up to roughly 100 threads per cm calculated in the longitudinal direction of the thread-shaped element.
  • the weft threads it is suitable for the weft threads to consist of the same type of thread as the other threads in the thread- shaped element.
  • the material in the threads should consist of a linear block polymer with a molecular weight of at least 10 4 Dalton, preferably at least 10 5 Dalton, comprising urea groups and urethane groups and also ester groups at such a distance from one another that, after hydrolysis of the same, fragments arise which are so small that they can be excreted from a human body, and also comprising primary NH 2 -end groups and/or OH-end groups which can be replaced by, for example, monoamines such as butylamine or ethylamine.
  • the implant according to the invention preferably consists of a central isotropic part for essentially absorbing constant loading, and a movable outer part for absorbing forces caused by extension and/or compression.
  • the implant consists of an articular ligament implant or tendon implant.
  • the figure shows a section of an articular ligament according to the present invention comprising only three thread bundles 1.
  • the articular ligament usually consists of, for example, 1 to 500 such thread bundles depending on where in the body it is to be used. As can be seen from the figure, these thread bundles 1 are lightly twisted with a twist of 10 to 150 revolutions per metre. This twist is primarily intended to prevent entanglement of filaments and/or threads across the width of the ligament.
  • the thread bundles 1 consist of up to several thousand threads
  • each thread bundle can thus contain a very large number of filaments from a few hundred up to several hundred thousand.
  • weft threads 3 which are preferably applied in a weaving machine and using the simplest possible type of weave, usually plain weave.
  • the distance between the weft threads can vary from a distribution density of a few threads per cm up to roughly 100 threads per cm depending on the desired firmness of the ligament. The closer the threads lie, the more rigid and firm the ligament.
  • the weft threads 3 suitably consist of the same material as the threads 2 in the thread bundles 1.
  • the thread bundles 2 do not have to have the same thickness throughout the ligament.
  • the implant is to be used as an articular ligament in a knee
  • the thread bundles can therefore slide somewhat in relation to one another.
  • the construction according to the invention is loose, which affords an enhanced possibility of immigration of connective tissue cells into the ligament.
  • the strength and the elasticity of the construction can be adapted, which makes it possible for the patient to be active soon after an operation, development of the correct type of collagen fibre thus being stimulated. Adaptation is effected by varying the number of thread bundles, the number of threads in the thread bundles and the density of the weft threads.
  • the strength in an articular ligament according to the present invention can vary between 50 MPa and 500 MPa.
  • the modulus of elasticity in an articular ligament according to the present invention can vary between 100 MPa and 1500 MPa.
  • the construction according to the present invention affords a number of advantages in comparison with previously known implants, namely maximum utilization of the thread strength as a result of a small filament angle in the fibre strand (small cosine ⁇ factor), and adapted but limited mobility between the fibre strands, a loose construction to enhance the possibility of immigration of the body's own connective tissue cells, and adapted strength and elasticity.
  • the material in the filaments and the threads should be degradable in the body and preferably consists of those linear block polymers comprising urea groups and urethane groups which comprise hydrolyzable ester groups and are described in Swedish patent specification 505703. Other materials which are degradable and resorbable in the body can also be used.

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Rehabilitation Therapy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
  • Braiding, Manufacturing Of Bobbin-Net Or Lace, And Manufacturing Of Nets By Knotting (AREA)
  • Yarns And Mechanical Finishing Of Yarns Or Ropes (AREA)

Abstract

The present invention relates to a porous, in humans or animals biodegradable, biocompatible implant for implantation in humans or animals, which implant comprises flexible, thread-shaped elements. The thread-shaped elements consist of a number of thread bundles (1) containing up to several thousand threads (2) which in turn contain 50 to 500 filaments with a combined density of 5 to 120 tex. The thread bundles (1) have a twist of 0 to 150 revolutions per metre and are held together by weft threads (3) with a distribution density of a few threads per cm up to roughly 100 threads per cm calculated in the longitudinal direction of the thread-shaped element.

Description

TITLE
Implant for implantation in humans or animals comprising flexible, thread- shaped elements
TECHNICAL FIELD The present invention relates to an implant for implantation in, in particular, humans, which implant comprises flexible, thread-shaped elements and is particularly suitable for replacing ruptured articular ligaments. The implant is intended to be a temporary implant which disintegrates in time into fragments which are so small that they can be transported away by the blood and excreted through the kidneys.
STATE OF THE ART
Every year, millions of people are affected by damage to articular ligaments and tendons. A damaged ligament can be treated by surgical intervention or by conservative therapy. In spite of the fact that leading orthopaedic experts agree that surgical intervention is to be preferred in most cases, conservative therapy remains the most frequently used alternative. A major reason for this is that existing operative techniques using existing implants are considered to be inadequate. A common feature of all types of reconstruction is that the surgeon has to use some form of replacement material to replace the damaged tissue. The most frequently used type of replacement material is tissue of the patient himself (autograft) which the surgeon takes from other parts of the body. This tissue is often supplemented with a synthetic material as reinforcement (augmentation implant). Alternatively, use is made of only a synthetic material (prosthetic implant). Implant materials which have been tried over the last 20 years in addition to autografts are inter alia tendons from animals (xenografts), deceased humans (allografts), synthetic materials in the form of non-degradable bands (Dacron, polyethylene, polypropylene, carbon fibres, polytetrafluoroethylene), and a degradable band made of polydioxanone.
Temporary implants for implantation in humans or animals comprising flexible, thread-shaped elements are previously known. One such has been described in Swedish patent specification 457392. The implant according to this patent specification consists of a bioresorbable material and is intended to replace completely or partly a tendon, a ligament or a cruciate ligament. The implant has an elongate shape and is flexible. Its main characteristic is that the structure has longitudinal grooves or ducts intended to serve as initial growth guides for new fibrous tissue. Furthermore, a large number of bioresorbable materials are also known and used for other types of implant.
TECHNICAL PROBLEM In certain cases, the synthetic non-degradable implant materials have proved to have inadequate tissue-affinity and in the majority of cases inadequate elasticity with creep or fatigue failure as a consequence.
Biological tendon tissue from the patient himself, animals or deceased humans has not proved to be an optimum alternative either. The absence of a natural blood supply means that the elasticity and the strength are already reduced after a few weeks. Moreover, there is always a risk of transmitting infection when using implants from other humans and animals. In cases where tissue is taken from other parts of the body, the patient may suffer temporary or permanent harm from the wound created at the place from where healthy tissue has been taken.
SOLUTION
It has therefore long been a requirement to produce a resorbable implant without the abovementioned shortcomings and, according to the following invention, a porous, in humans or animals biodegradable, biocompatible implant for implantation in humans or animals comprising flexible, thread-shaped elements has consequently been produced, which is characterized in that the thread-shaped elements consist of a number of thread bundles containing up to several thousand threads which in turn contain 50 to 500 filaments with a combined density of 5 to 120 tex, the thread bundles having a twist of 0 to 150 revolutions/metre and being held together by weft threads with a distribution density of a few threads per cm up to roughly 100 threads per cm calculated in the longitudinal direction of the thread-shaped element. According to the invention, it is suitable for the weft threads to consist of the same type of thread as the other threads in the thread- shaped element.
According to the invention, the material in the threads should consist of a linear block polymer with a molecular weight of at least 104 Dalton, preferably at least 105 Dalton, comprising urea groups and urethane groups and also ester groups at such a distance from one another that, after hydrolysis of the same, fragments arise which are so small that they can be excreted from a human body, and also comprising primary NH2-end groups and/or OH-end groups which can be replaced by, for example, monoamines such as butylamine or ethylamine.
The implant according to the invention preferably consists of a central isotropic part for essentially absorbing constant loading, and a movable outer part for absorbing forces caused by extension and/or compression.
According to the invention, the implant consists of an articular ligament implant or tendon implant.
DESCRIPTION OF THE FIGURE The invention will be described in greater detail below with reference to the appended figure which shows in perspective what an embodiment of the implant according to the present invention looks like.
DETAILED DESCRIPTION The figure shows a section of an articular ligament according to the present invention comprising only three thread bundles 1. The articular ligament usually consists of, for example, 1 to 500 such thread bundles depending on where in the body it is to be used. As can be seen from the figure, these thread bundles 1 are lightly twisted with a twist of 10 to 150 revolutions per metre. This twist is primarily intended to prevent entanglement of filaments and/or threads across the width of the ligament.
The thread bundles 1 consist of up to several thousand threads
2 which in turn each contain 50 to 500 filaments. Each thread bundle can thus contain a very large number of filaments from a few hundred up to several hundred thousand.
In order for the thread bundles 1 to be held together, they are bound together by weft threads 3 which are preferably applied in a weaving machine and using the simplest possible type of weave, usually plain weave. The distance between the weft threads can vary from a distribution density of a few threads per cm up to roughly 100 threads per cm depending on the desired firmness of the ligament. The closer the threads lie, the more rigid and firm the ligament. The weft threads 3 suitably consist of the same material as the threads 2 in the thread bundles 1. The thread bundles 2 do not have to have the same thickness throughout the ligament. If the implant is to be used as an articular ligament in a knee, it is suitable for the thread bundles in the central part of the ligament to be made somewhat thicker than the outer parts so that loads across the ligament are as much like the autologous ligament as possible, that is to say with a central isotropic part which is essentially to absorb constant loading while the outer thread bundles can be more easily movable so as to be capable of freeiy absorbing the forces caused by extension and/or compression which arise, for example, during bending and torsion of a knee joint. The thread bundles can therefore slide somewhat in relation to one another.
The construction according to the invention is loose, which affords an enhanced possibility of immigration of connective tissue cells into the ligament. The strength and the elasticity of the construction can be adapted, which makes it possible for the patient to be active soon after an operation, development of the correct type of collagen fibre thus being stimulated. Adaptation is effected by varying the number of thread bundles, the number of threads in the thread bundles and the density of the weft threads. The strength in an articular ligament according to the present invention can vary between 50 MPa and 500 MPa. The modulus of elasticity in an articular ligament according to the present invention can vary between 100 MPa and 1500 MPa.
The construction according to the present invention affords a number of advantages in comparison with previously known implants, namely maximum utilization of the thread strength as a result of a small filament angle in the fibre strand (small cosine φ factor), and adapted but limited mobility between the fibre strands, a loose construction to enhance the possibility of immigration of the body's own connective tissue cells, and adapted strength and elasticity. The material in the filaments and the threads should be degradable in the body and preferably consists of those linear block polymers comprising urea groups and urethane groups which comprise hydrolyzable ester groups and are described in Swedish patent specification 505703. Other materials which are degradable and resorbable in the body can also be used.
The invention is not limited to the embodiment described above but can be modified in various ways within the scope of the patent claims.

Claims

PATENT CLAIMS
1. Porous, in humans or animals biodegradable, biocompatible implant for implantation in humans or animals comprising flexible, thread- shaped elements, characterized in that the thread-shaped elements consist of a number of thread bundles (1 ) containing up to several thousand threads (2) which in turn contain 50 to 500 filaments with a combined density of 5 to 120 tex, the thread bundles (1 ) having a twist of 0 to 150 revolutions per metre and being held together by weft threads (3) with a distribution density of a few threads per cm up to roughly 100 threads per cm calculated in the longitudinal direction of the thread- shaped element.
2. Implant according to Claim 1 , characterized in that the weft threads (3) consist of the same type of thread as the other threads (2) in the thread-shaped element.
3. Implant according to any one of Claims 1 and 2, characterized in that the material in the threads (2) consists of linear block polymers with a molecular weight of at least 104 Dalton, preferably at least 105 Dalton, comprising urea groups and urethane groups and also ester groups at such a distance from one another that, after hydrolysis of the same, fragments arise which are so small that they can be excreted from a human body, and also comprising primary NH2-end groups and/or OH-end groups which can be replaced by, for example, monoamines such as butylamine or ethylamine.
4. Implant according to any one of Claims 1-3, characterized in that the implant consists of a central isotropic part for essentially absorbing constant loading, and a more movable outer part for absorbing forces caused by extension and/or compression.
5. Implant according to any one of Claims 1-4, characterized in that it consists of an articular ligament implant or tendon implant.
PCT/SE1999/002185 1998-12-15 1999-11-25 Implant for implantation in humans or animals comprising flexible, thread-shaped elements WO2000035507A1 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
KR1020017007350A KR20010089569A (en) 1998-12-15 1999-11-25 Implant for implantation in humans or animals comprising flexible, thread-shaped elements
HU0104461A HUP0104461A3 (en) 1998-12-15 1999-11-25 Implant for implantation in humans or animals or comprising flexible, thread-shaped elements
DE69905198T DE69905198T2 (en) 1998-12-15 1999-11-25 FLEXIBLE, THREADED IMPLANT ELEMENTS FOR PEOPLE AND ANIMALS
BR9916030-7A BR9916030A (en) 1998-12-15 1999-11-25 Implant for implantation in humans or animals comprising flexible, wire-shaped elements
SI9920088A SI20622A (en) 1998-12-15 1999-11-25 Implant for implantation in humans or animals comprising flexible, thread-shaped elements
EP99973391A EP1140236B1 (en) 1998-12-15 1999-11-25 Implant for implantation in humans or animals comprising flexible, thread-shaped elements
US09/868,055 US6626942B1 (en) 1998-12-15 1999-11-25 Implant for implantation in humans or animals comprising flexible thread-shaped elements
PL99347670A PL347670A1 (en) 1998-12-15 1999-11-25 Implant for implantation in humans or animals comprising flexible, thread-shaped elements
AU14388/00A AU751967B2 (en) 1998-12-15 1999-11-25 Implant for implantation in humans or animals comprising flexible, thread-shaped elements
SK479-2001A SK4792001A3 (en) 1998-12-15 1999-11-25 Implant for implantation in humans or animals comprising flexible, thread-shaped elements
IL14362799A IL143627A0 (en) 1998-12-15 1999-11-25 Implant for implantation in humans or animals comprising flexible, thread-shaped elements
CA002354448A CA2354448A1 (en) 1998-12-15 1999-11-25 Implant for implantation in humans or animals comprising flexible, thread-shaped elements
NZ511709A NZ511709A (en) 1998-12-15 1999-11-25 Implant for implantation in humans or animals comprising flexible, thread-shaped elements
AT99973391T ATE231731T1 (en) 1998-12-15 1999-11-25 FLEXIBLE, THINK-SHAPED IMPLANT ELEMENTS FOR HUMAN AND ANIMALS
DK99973391T DK1140236T3 (en) 1998-12-15 1999-11-25 Implant for implantation in humans or animals, which contains flexible, filamentous elements.
JP2000587825A JP2002532156A (en) 1998-12-15 1999-11-25 Implant for implantation into a human or animal containing a flexible thread-like element
NO20012613A NO20012613L (en) 1998-12-15 2001-05-28 Implant for implantation in humans or animals including flexible filamentous elements
HK02104519.2A HK1042658A1 (en) 1998-12-15 2002-06-18 Implant for implantation in humans or animals comprising flexible, thread-shaped elements

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9804321-9 1998-12-15
SE9804321A SE513491C2 (en) 1998-12-15 1998-12-15 Implants for insertion into humans or animals including flexible filamentous elements

Publications (1)

Publication Number Publication Date
WO2000035507A1 true WO2000035507A1 (en) 2000-06-22

Family

ID=20413655

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SE1999/002185 WO2000035507A1 (en) 1998-12-15 1999-11-25 Implant for implantation in humans or animals comprising flexible, thread-shaped elements

Country Status (26)

Country Link
US (1) US6626942B1 (en)
EP (1) EP1140236B1 (en)
JP (1) JP2002532156A (en)
KR (1) KR20010089569A (en)
CN (1) CN1191098C (en)
AR (1) AR021649A1 (en)
AT (1) ATE231731T1 (en)
AU (1) AU751967B2 (en)
BR (1) BR9916030A (en)
CA (1) CA2354448A1 (en)
DE (1) DE69905198T2 (en)
DK (1) DK1140236T3 (en)
ES (1) ES2192106T3 (en)
HK (1) HK1042658A1 (en)
HU (1) HUP0104461A3 (en)
IL (1) IL143627A0 (en)
NO (1) NO20012613L (en)
NZ (1) NZ511709A (en)
PL (1) PL347670A1 (en)
PT (1) PT1140236E (en)
SE (1) SE513491C2 (en)
SI (1) SI20622A (en)
SK (1) SK4792001A3 (en)
TR (1) TR200101362T2 (en)
WO (1) WO2000035507A1 (en)
ZA (1) ZA997360B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2466073A (en) * 2008-12-12 2010-06-16 Univ Manchester Tissue repair scaffold

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI119097B (en) * 2004-08-31 2008-07-31 Bioretec Oy Surgical thread and surgical instrument
ATE539102T1 (en) * 2006-10-31 2012-01-15 Surmodics Pharmaceuticals Inc SPHERICAL POLYMER PARTICLES
WO2008097901A1 (en) * 2007-02-02 2008-08-14 Tornier, Inc. System and method for repairing tendons and ligaments
US7887586B2 (en) * 2007-09-17 2011-02-15 Linares Medical Devices, Llc Artificial ligaments for joint applications
US8328875B2 (en) 2009-12-30 2012-12-11 Linares Medical Devices, Llc Combination male/female hip joint and installation kit
US8211182B2 (en) 2007-09-17 2012-07-03 Linares Medical Devices, Llc Hip socket with assembleable male ball shape having integrally formed ligament and female receiver and installation kit
KR101109543B1 (en) * 2009-12-15 2012-02-06 한밭대학교 산학협력단 System for portable real-time braille information transceiving and outputting
US20110190886A1 (en) * 2010-01-29 2011-08-04 Wisconsin Alumni Research Foundation Braided tertiary nanofibrous structure for ligament, tendon, and muscle tissue implant
US8702800B2 (en) 2011-08-23 2014-04-22 Linares Medical Devices, Llc Multi-component shoulder implant assembly with dual articulating surfaces
US20150335440A1 (en) 2011-08-23 2015-11-26 Linares Medical Devices, Llc Multi-component implant assembly with dual articulating and/or rotating surfaces
US8864835B2 (en) 2011-08-24 2014-10-21 Linares Medical Devices, Llc Multi-component knee implant assembly with multiple articulating and traveling surfaces
US8702802B2 (en) 2011-08-29 2014-04-22 Linares Medical Devices, Llc Knee implant assembly with rotary bearing supported and traveling surfaces
US8753403B2 (en) 2011-08-30 2014-06-17 Linares Medical Devices, Llc Multi-component knee implant assembly with combined articulating and belt support and traveling surfaces
CN107510520B (en) * 2017-09-21 2020-08-11 上海松力生物技术有限公司 Cruciate ligament regenerative implant and preparation method and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116372A (en) * 1986-05-07 1992-05-26 Laboureau Jacques Philippe Artificial ligament in synthetic materials impregnated and coated with elastic resin and its coating procedure
WO1997022643A1 (en) * 1995-12-15 1997-06-26 Artimplant Development Artdev Ab Linear block polymer comprising urea and urethane groups, method for the production of linear block polymers and use of the block polymers as implants

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4834755A (en) * 1983-04-04 1989-05-30 Pfizer Hospital Products Group, Inc. Triaxially-braided fabric prosthesis
US5192332A (en) * 1983-10-14 1993-03-09 L'oreal Cosmetic temporary coloring compositions containing protein derivatives
US4792336A (en) * 1986-03-03 1988-12-20 American Cyanamid Company Flat braided ligament or tendon implant device having texturized yarns
US4987665A (en) * 1986-03-03 1991-01-29 American Cyanamid Company Prosthetic tubular article
US5425766A (en) * 1987-03-09 1995-06-20 Astra Tech Aktiebolag Resorbable prosthesis
SE457692B (en) 1987-03-09 1989-01-23 Astra Meditec Ab IMPLANT PROTECTION PROVIDES WHOLE OR PARTIAL REPLACEMENT OF A SENA, A LIQUOR OR A CROSS BAND
US5263984A (en) * 1987-07-20 1993-11-23 Regen Biologics, Inc. Prosthetic ligaments
US4883486A (en) * 1988-05-31 1989-11-28 Indu Kapadia Prosthetic ligament
US5217495A (en) * 1989-05-10 1993-06-08 United States Surgical Corporation Synthetic semiabsorbable composite yarn
US5004474A (en) * 1989-11-28 1991-04-02 Baxter International Inc. Prosthetic anterior cruciate ligament design
GB9306737D0 (en) * 1993-03-31 1993-05-26 Surgicarft Ltd Ligament augmentation device
EP0677297B1 (en) * 1993-09-24 2000-12-13 Takiron Co. Ltd. Implantation material
FR2755846B1 (en) * 1996-11-20 1998-12-31 Jacques Philippe Laboureau PRE-ORIENT PROSTHETIC LIGAMENT AND METHOD OF MAKING

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116372A (en) * 1986-05-07 1992-05-26 Laboureau Jacques Philippe Artificial ligament in synthetic materials impregnated and coated with elastic resin and its coating procedure
WO1997022643A1 (en) * 1995-12-15 1997-06-26 Artimplant Development Artdev Ab Linear block polymer comprising urea and urethane groups, method for the production of linear block polymers and use of the block polymers as implants

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2466073A (en) * 2008-12-12 2010-06-16 Univ Manchester Tissue repair scaffold
US9770529B2 (en) 2008-12-12 2017-09-26 The University Of Manchester Tissue repair scaffold

Also Published As

Publication number Publication date
JP2002532156A (en) 2002-10-02
PL347670A1 (en) 2002-04-22
AU1438800A (en) 2000-07-03
AR021649A1 (en) 2002-07-31
CN1191098C (en) 2005-03-02
PT1140236E (en) 2003-06-30
SE9804321L (en) 2000-06-16
HK1042658A1 (en) 2002-08-23
HUP0104461A2 (en) 2002-03-28
BR9916030A (en) 2001-08-28
ES2192106T3 (en) 2003-09-16
DE69905198D1 (en) 2003-03-06
CN1330560A (en) 2002-01-09
NO20012613D0 (en) 2001-05-28
SE9804321D0 (en) 1998-12-15
SI20622A (en) 2002-02-28
EP1140236A1 (en) 2001-10-10
CA2354448A1 (en) 2000-06-22
NO20012613L (en) 2001-05-28
TR200101362T2 (en) 2002-02-21
ATE231731T1 (en) 2003-02-15
NZ511709A (en) 2003-02-28
ZA997360B (en) 2001-01-03
HUP0104461A3 (en) 2002-08-28
DK1140236T3 (en) 2003-05-05
SE513491C2 (en) 2000-09-18
EP1140236B1 (en) 2003-01-29
KR20010089569A (en) 2001-10-06
DE69905198T2 (en) 2003-10-23
IL143627A0 (en) 2002-04-21
SK4792001A3 (en) 2001-10-08
AU751967B2 (en) 2002-09-05
US6626942B1 (en) 2003-09-30

Similar Documents

Publication Publication Date Title
EP1140236B1 (en) Implant for implantation in humans or animals comprising flexible, thread-shaped elements
US5092887A (en) Artificial ligament produced from demineralized bone for the replacement and augmentation of ligaments, tendons and other fibrous connective tissue
US5458636A (en) Prosthetic device for repair and replacement of fibrous connective tissue
KR950001375B1 (en) Surgical repair device
EP0955949B1 (en) Strength enhancement of collagen constructs
US4932972A (en) Prosthetic ligament
EP1187579B1 (en) Implants for connective tissue reconstruction
CN1917909A (en) Designed composite degradation for spinal implants
CN102164563A (en) Fracture fixation systems
Freeman et al. Recent advancements in ligament tissue engineering: the use of various techniques and materials for ACL repair
US20230055112A1 (en) Collagen Construct and Method for Producing the Collagen Construct
WO2000018332A1 (en) Chute for endosteal ligament fixation
MXPA01004077A (en) Implant for implantation in humans or animals comprising flexible, thread-shaped elements
Moran Materials for ligament replacement
Freeman Tissue engineered devices for ligament repair, replacement and regeneration
CA2260153C (en) Strength enhancement of collagen constructs
Silver et al. Replacement of Skeletal Tissues
NZ730479B2 (en) Collagen construct and method for producing the collagen construct

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 99814546.7

Country of ref document: CN

ENP Entry into the national phase

Ref document number: 2000 14388

Country of ref document: AU

Kind code of ref document: A

AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LT LU LV MA MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: PV2001-1198

Country of ref document: CZ

WWE Wipo information: entry into national phase

Ref document number: 4792001

Country of ref document: SK

ENP Entry into the national phase

Ref document number: 2000 587825

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1200100351

Country of ref document: VN

WWE Wipo information: entry into national phase

Ref document number: PA/a/2001/004077

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 14388/00

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 511709

Country of ref document: NZ

Ref document number: 2001/01362

Country of ref document: TR

WWE Wipo information: entry into national phase

Ref document number: 9920088

Country of ref document: SI

WWE Wipo information: entry into national phase

Ref document number: 1999973391

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 143627

Country of ref document: IL

ENP Entry into the national phase

Ref document number: 2354448

Country of ref document: CA

Ref document number: 2354448

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1020017007350

Country of ref document: KR

Ref document number: 09868055

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: PV2001-1198

Country of ref document: CZ

WWP Wipo information: published in national office

Ref document number: 1020017007350

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 1999973391

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 14388/00

Country of ref document: AU

WWG Wipo information: grant in national office

Ref document number: 1999973391

Country of ref document: EP

WWR Wipo information: refused in national office

Ref document number: PV2001-1198

Country of ref document: CZ

WWW Wipo information: withdrawn in national office

Ref document number: 1020017007350

Country of ref document: KR